Medicine
Divalproex 125 mg delayed-release tablet
Divalproex 125 mg delayed-release tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Divalproex
- Brand
- Sold under the generic name
- Strength
- 125 mg
- Dosage form
- Delayed-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 10 blister pack and 30 more
- Manufacturers
- Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaDr. Reddy's LaboratoriesIndiaUnichem LaboratoriesIndiaA-S Medication SolutionsBionpharmaRemedyrepackBluePoint LaboratoriesRising Pharma HoldingsAmerican Health Packaging13 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AG01 Valproic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 July 2008
- Identifiers
- RxCUI 1099625, 1099678, 1099870DailyMed set ID 19064624-81d1-4ce3-bfe4-955bad6af6a2, 02304a23-4a5f-47bc-9687-4044b43f7a20, f936b9d0-a58f-4fa5-8db9-752dabb837a6 +12NDC 69452-433, 0832-7122, 0615-8586 +12Application ANDA078853, ANDA078182, ANDA079163 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, delayed release in 1 bottle | 65862-959-01 | Aurobindo PharmaIndia | 24 October 2014 |
| 500 tablet, delayed release in 1 bottle | 65862-959-05 | Aurobindo PharmaIndia | 24 October 2014 |
| 10 blister pack in 1 carton / 10 tablet, delayed release in 1 blister pack | 65862-959-10 | Aurobindo PharmaIndia | 24 October 2014 |
| 7000 tablet, delayed release in 1 bottle | 65862-959-71 | Aurobindo PharmaIndia | 24 October 2014 |
| 1000 tablet, delayed release in 1 bottle | 65862-959-99 | Aurobindo PharmaIndia | 24 October 2014 |
| 100 tablet, delayed release in 1 bottle | 55111-529-01 | Dr. Reddy's LaboratoriesIndia | 29 July 2008 |
| 500 tablet, delayed release in 1 bottle | 55111-529-05 | Dr. Reddy's LaboratoriesIndia | 29 July 2008 |
| 30 tablet, delayed release in 1 bottle | 55111-529-30 | Dr. Reddy's LaboratoriesIndia | 29 July 2008 |
| 10 blister pack in 1 carton / 10 tablet, delayed release in 1 blister pack | 55111-529-78 | Dr. Reddy's LaboratoriesIndia | 29 July 2008 |
| 100 tablet, delayed release in 1 bottle | 62756-796-08 | Sun Pharmaceutical IndustriesIndia | 29 July 2008 |
| 500 tablet, delayed release in 1 bottle | 62756-796-13 | Sun Pharmaceutical IndustriesIndia | 29 July 2008 |
| 1000 tablet, delayed release in 1 bottle | 62756-796-18 | Sun Pharmaceutical IndustriesIndia | 29 July 2008 |
| 30 tablet, delayed release in 1 bottle | 62756-796-83 | Sun Pharmaceutical IndustriesIndia | 29 July 2008 |
| 100 tablet, delayed release in 1 bottle | 62756-796-88 | Sun Pharmaceutical IndustriesIndia | 29 July 2008 |
| 100 tablet, delayed release in 1 bottle, plastic | 29300-138-01 | Unichem LaboratoriesIndia | 1 October 2011 |
| 500 tablet, delayed release in 1 bottle, plastic | 29300-138-05 | Unichem LaboratoriesIndia | 1 October 2011 |
| 1000 tablet, delayed release in 1 bottle, plastic | 29300-138-10 | Unichem LaboratoriesIndia | 1 October 2011 |
| 30 tablet, delayed release in 1 bottle | 69452-433-13 | Bionpharma | 26 June 2024 |
| 100 tablet, delayed release in 1 bottle | 69452-433-20 | Bionpharma | 26 June 2024 |
| 500 tablet, delayed release in 1 bottle | 69452-433-30 | Bionpharma | 26 June 2024 |
| 100 tablet, delayed release in 1 bottle | 57237-106-01 | Rising Pharma Holdings | 24 October 2014 |
| 500 tablet, delayed release in 1 bottle | 57237-106-05 | Rising Pharma Holdings | 24 October 2014 |
| 100 tablet, delayed release in 1 bottle | 0832-7122-11 | Upsher-Smith Laboratories | 21 March 2014 |
| 30 tablet, delayed release in 1 bottle | 50090-4861-0 | A-S Medication Solutions | 22 January 2020 |
| 30 tablet, delayed release in 1 bottle | 50090-7121-0 | A-S Medication Solutions | 27 March 2024 |
| 30 tablet, delayed release in 1 bottle | 50090-7635-0 | A-S Medication Solutions | 18 August 2025 |
| 30 blister pack in 1 carton / 1 tablet, delayed release in 1 blister pack | 60687-857-21 | American Health Packaging | 17 March 2025 |
| 100 tablet, delayed release in 1 bottle, plastic | 68001-472-00 | BluePoint Laboratories | 20 January 2021 |
| 500 tablet, delayed release in 1 bottle, plastic | 68001-472-03 | BluePoint Laboratories | 20 January 2021 |
| 30 tablet, delayed release in 1 blister pack | 70518-3683-0 | Remedyrepack | 17 March 2023 |
| 30 tablet, delayed release in 1 blister pack | 70518-3683-1 | Remedyrepack | 13 September 2023 |
| 30 tablet, delayed release in 1 bottle, plastic | 70518-3683-2 | Remedyrepack | 1 July 2025 |
| 30 tablet, delayed release in 1 blister pack | 0615-8586-39 | Vangard Labs | 20 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 March 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Divalproex 125 mg delayed-release tablet.
Other strengths and forms of Divalproex
Clinical summary
Divalproex is an anti-epileptic agent indicated for treatment of manic episodes associated with bipolar disorder, among other approved uses. It is available as delayed-release tablets, extended-release tablets and capsules for oral use. MedsAcross supplies Divalproex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DivalproexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Depakote prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
Need Divalproex 125 mg delayed-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.